D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
SHANGHAI, Dec. 10, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The...
FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION
MUSCAT, Oman, Nov. 20, 2024 /PRNewswire/ -- Future Fund Oman (FFO), the latest investment initiative under Oman Investment Authority (OIA), has announced its first batch of approved investment projects. With a combined value exceeding US$ 2 billion,...